Navigation Links
Verum.de Chosen to Provide Clinical Research Services for Oncology Center in Romania
Date:1/23/2013

SAN DIEGO, Jan. 23, 2013 /PRNewswire/ -- Verum.de, a full-clinical service, German-based contract research organization (CRO) with a new office in Carlsbad, Calif., has entered into an agreement with the Center for Oncologic Diagnosis and Treatment (Oncocard) in Romania to be its preferred provider of clinical trial services. The center, developed with the first private investment funding in oncology in Romania, is brand new and features state-of-the-art services and equipment. The center selected Verum.de as their CRO of choice so they could assist with running clinical trials and offer patients all possible treatment options.  

(Logo:  http://photos.prnewswire.com/prnh/20120807/LA53176LOGO)

"The esteemed medical professionals involved with the center provide patients a sophisticated level of treatment and services that are rare for the area," stated Verum's local Romanian Medical Director Laurentiu Nedelcu , a doctor and pharmacologist who has supervised Verum trials since 1996. "Verum is known for its regional expertise, and we're pleased to be the CRO the center has chosen to work with."

The Oncology Center, which opened in June, 2012, is a 86,112 sq. feet clinic offering full spectrum oncologic chemotherapy, radiotherapy, treatment of hematological malignancies and surgical services to patients in addition to serving as an investigative center for research. The Oncology Center's medical staff is highly qualified and many of the Oncology Center's staff doctors have experience working with Verum. To date, more than 1,700 patients have been treated at the facility and more than 3,800 investigations have been performed.

"The center was opened to offer a higher level of care to cancer patients, with the best services and equipment modern medicine has available," explained the center's Medical Director, Dr. Mihai Ciochinaru . "We trust working with a CRO such as Verum, which runs trials in an efficient, highly ethical manner and understands the region."

Verum provides clinical trial services with Western standards in Central and Eastern European countries (CEE) and former Soviet bloc countries. Verum recently opened a U.S. office in Carlsbad to assist U.S. clients with international trials, and the new office is headed by Kristi Clark , an industry veteran with more than 20 years of pharma and biotech experience in both large and mid-size CROs.

About Verum.de
German-based Verum.de was founded by Christian Sacher and Jutta Minkner (CFO), two industry pioneers with more than 25 years experience running clinical trials in CEE and former Soviet bloc countries. Verum has more than 100 office based employees operating out of eight locations, including its Munich headquarters, and the company offers therapeutic specialties in cardiovascular, neurology, psychiatry, CNS, oncology and pain, among others. Verum started operations in 1992 in CEE countries based on Western ideals and ethical standards. Verum has substantial contacts with local authorities, and is known in CEE for the flexible and responsive services it provides. More information can be found at http://www.verum.de

CONTACT:
Rachel Hutman
Clearpoint Agency, for Verum.de
rachel@clearpointagency.com
760-230-2424


'/>"/>
SOURCE Verum.de
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Providence Health & Services Selects Conflict of Interest Management System
2. Jet-lagged fruit flies provide clues for body clock synchronisation
3. Sustainable Valley Technology Group Provides Technology Innovation Grant To Help Researchers & Start-Ups With Funding, Business Support, Equipment & Facilities
4. Bottom-up approach provides first characterization of pyroelectric nanomaterials
5. Mobility and Big Data Analytics Provider NuWare Announces the Appointment of Rohit Shyam as Chief Strategy & Marketing Officer
6. Stem Cell and Telomere Support Provided by Stem Cell 100 from Life Code
7. RAPS, Eucomed Partner to Provide Online Training to Regulatory Professionals Throughout Europe
8. Galileo Analytics Announces Agreement to Provide Analytic Component of ASCOs CancerLinQ Prototype
9. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
10. Bayer CropScience Provides a Glimpse of SeedGrowth™ Innovation
11. Organovo Reports Q3 2012 Financial Results, Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... According to a new market research report "Oligonucleotide Synthesis Market ... (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), End user (Academic, Pharmaceutical, ... is expected to reach USD 2.20 Billion by 2021 from USD ... forecast period. Continue Reading ... ...
(Date:12/8/2016)... ... 2016 , ... From wearable devices that can improve performance ... Thursday, December 15th a panel of entrepreneurs, innovators and a Philadelphia Eagles front ... Smart Talk session. Smart Talk will run from 8:30 – 10:30 a.m. at ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... — optogenetics — is key to exciting advances in the study and mapping ... light projected via free-space optics stimulates small, transparent organisms and excites neurons within ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc ... to client demand KbioBox developed a sophisticated “3 click” gene dditing off target ... from KBioBox’s new website, https://www.kbiobox.com/ and powered by the company’s ...
Breaking Biology Technology:
(Date:12/7/2016)... , Dec. 7, 2016   Veridium , ... the appointment of new CEO James Stickland ... with decades of experience, has served in senior ... where he specialized in expanding a pipeline of ... portfolios. He most recently served as managing director ...
(Date:12/5/2016)... , Dec. 5, 2016  The Office of ... published "Can CT Scans Enhance or Replace Medico ... potential of supporting or replacing forensic autopsies with ... scan. In response to recommendations made ... exploring using CT scans as a potential component ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH ... new partnership initiative targeting national brands, industry thought-leaders ... reward their respective audiences for taking steps to ... its inception in 2012, higi has built the ... impacting over 38 million people who have conducted ...
Breaking Biology News(10 mins):